Raremoon Regulatory Affairs

We work exclusively on orphan drugs and advanced therapies. We advise, plan, develop, write, review, and submit regulatory dossiers. Regulatory specialists with a purpose: We are senior regulatory experts offering strategic and operational support to global biotech companies developing orphan drugs and advanced therapies. With more than 300 years of combined experience, our team of regulatory pioneers possesses comprehensive knowledge of orphan drugs, advanced therapies, and strategic global requirements. Our deep expertise is derived from facilitating hundreds of global agency interactions and successful regulatory programs. We are your dedicated regulatory partner: We partner with clients who, like us, are driven by a passion and purpose to bring rare disease therapies to patients. Designing a clinical trial and an accompanying regulatory pathway requires critical, creative, and reliable thinking. We don’t see regulations as a hurdle. We see them as the runway to patient access and marketing. We will prioritize, define, and accomplish regulatory milestones by collaborating with regulators and driving integrated CMC, nonclinical, clinical, and regulatory strategies. We provide a broad range of services and expertise to accommodate any regulatory need. Collective expertise and insights across our entire practice: When you work with us, you'll be partnered with a dedicated team that will focus on your project. Your team will work collaboratively, with access to collective expertise and insights from our entire practice. This ensures that every aspect of your project benefits from the broad knowledge and experience of our entire organization, offering a comprehensive, well-rounded approach to your needs Visit our website to hear what our clients are saying about us.